Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Heart

• Publication date

  2017-02-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/heartjnl-2016-310509PMID 28237968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Catecholaminergic polymorphic ventricular tachycardia

  2020cited by this paper
• Syncope clinical management in the emergency department: a consensus from the first international workshop on syncope risk stratification in the emergency department.

  2016cited by this paper
• Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia.

  2016cited by this paper
• Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications.

  2016cited by this paper
• Flecainide exerts paradoxical effects on sodium currents and atrial arrhythmia in murine RyR2-P2328S hearts

  2015cited by this paper
• Catecholaminergic Polymorphic Ventricular Tachycardia in Children: Analysis of Therapeutic Strategies and Outcomes From an International Multicenter Registry

  2015cited by this paper
• Alternating membrane potential/calcium interplay underlies repetitive focal activity in a genetic model of calcium‐dependent atrial arrhythmias

  2015cited by this paper
• Suppression of Spontaneous Ca Elevations Prevents Atrial Fibrillation in Calsequestrin 2-Null Hearts

  2014cited by this paper
• Catecholaminergic polymorphic ventricular tachycardia: from bench to bedside

  2013cited by this paper
• HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.

  2013cited by this paper
• Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia: Disease Penetrance and Expression in Cardiac Ryanodine Receptor Mutation–Carrying Relatives

  2012influential reference
• Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.

  2012cited by this paper
• Calcium Leak Through Ryanodine Receptors Leads to Atrial Fibrillation in 3 Mouse Models of Catecholaminergic Polymorphic Ventricular Tachycardia

  2012cited by this paper
• Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.

  2011cited by this paper
• Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.

  2011cited by this paper
• Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis.

  2011cited by this paper
• High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.

  2010cited by this paper
• The Diagnosis and Management of Syncope

  2010cited by this paper
• Guidelines for the diagnosis and management of syncope (version 2009).

  2009cited by this paper
• Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia

  2009cited by this paper
• The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.

  2009cited by this paper
• Systematic Assessment of Patients With Unexplained Cardiac Arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER)

  2009cited by this paper
• ARVC-Related Mutations in Divergent Region 3 Alter Functional Properties of the Cardiac Ryanodine Receptor

  2008cited by this paper
• Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia.

  2007cited by this paper
• Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients

  2005cited by this paper
• Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia

  2002cited by this paper
• Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers.

  2002cited by this paper
• Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia

  2001cited by this paper
• A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.

  2001cited by this paper
• Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia

  2001cited by this paper
• Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.

  1995cited by this paper

• Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification.

  2025cites this paper
• Long-term clinical course of patients with catecholaminergic polymorphic ventricular tachycardia: A more than 10-year follow-up cohort study

  2024cites this paper
• Genetic and clinical characteristics of catecholaminergic polymorphic ventricular tachycardia in a Taiwanese nationwide cohort.

  2024cites this paper
• CASQ2: clinical and genetic insights into catecholaminergic polymorphic ventricular tachycardia across three families

  2023cites this paper
• Clinical Genetics of Inherited Arrhythmogenic Disease in the Pediatric Population

  2022cites this paper
• Classic Presentation of Catecholaminergic Polymorphic Ventricular Tachycardia: A Case Report

  2022influential citation
• Pooled Analysis of Complications with Transvenous ICD Compared to Subcutaneous ICD in Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia

  2022cites this paper
• A Type 2 Ryanodine Receptor Variant in the Helical Domain 2 Associated with an Impairment of the Adrenergic Response

  2021cites this paper
• Cardiovascular Disease

  2021cites this paper
• Mechanisms underlying pathological Ca2+ handling in diseases of the heart

  2021cites this paper
• Specific Populations: Paediatric and Adolescent Athletes

  2020cites this paper
• The central domain of cardiac ryanodine receptor governs channel activation, regulation, and stability

  2020influential citation
• Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy

  2019cites this paper
• Congenital myopathies are mainly associated with a mild cardiac phenotype

  2019cites this paper
• 50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) - Time to Explore the Dark Side of the Moon.

  2019cites this paper
• Targeted next generation sequencing in a young population with suspected inherited malignant cardiac arrhythmias

  2018cites this paper
• New Progress in Understanding the Cellular Mechanisms of Anti-arrhythmic Drugs

  2018cites this paper
• Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review.

  2018cites this paper
• Outcome of clinical management in relatives of sudden cardiac death victims.

  2018cites this paper
• Clinical Implication of Multifocal Atrial Tachycardia in Children for Pediatric Cardiologist

  2018cites this paper
• The Complexity of Pediatric Multifocal Atrial Tachycardia and Its Prognostic Factors

  2017cites this paper
• Heartbeat: Text messaging to improve health

  2017cites this paper
• Catecholaminergic polymorphic tachycardia: underestimated and overtreated?

  2017cites this paper